Tempero Bio

Oakland, United States

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

$70.0M raised

Mar 2025

Series B

Top Investors

Khosla Ventures8VCAditum Bio

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Tempero Bio raised?

Tempero Bio has raised $70.0M in total funding. The most recent round was Series B. The last funding was announced in March 2025.

Who are Tempero Bio's investors?

Tempero Bio's investors include Khosla Ventures, 8VC, Aditum Bio.

Where is Tempero Bio headquartered?

Tempero Bio is headquartered in Oakland, United States.

What does Tempero Bio do?

Tempero Bio develops treatments for Substance Use Disorders as a clinical-stage biopharmaceutical company.

What stage is Tempero Bio at?

Tempero Bio is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated March 24, 2025.

MLA

"Tempero Bio — Funding & Investors." VCBacked, March 24, 2025, https://www.vcbacked.co/company/tempero-bio. Accessed June 3, 2026.

APA

VCBacked. (2025). Tempero Bio — Funding & Investors. Retrieved June 3, 2026, from https://www.vcbacked.co/company/tempero-bio

Wikipedia (cite web)

{{cite web |title=Tempero Bio — Funding & Investors |url=https://www.vcbacked.co/company/tempero-bio |website=VCBacked |access-date=June 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated March 24, 2025.